Smithtown Primary Medical Care, P.c. | |
100 Maple Ave Smithtown NY 11787-3502 | |
(631) 265-7671 | |
(631) 265-7692 |
Full Name | Smithtown Primary Medical Care, P.c. |
---|---|
Speciality | Family Medicine |
Location | 100 Maple Ave, Smithtown, New York |
Authorized Official Name and Position | Ronald Roth (PRESIDENT) |
Authorized Official Contact | 6312657671 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Smithtown Primary Medical Care, P.c. 100 Maple Ave Smithtown NY 11787-3502 Ph: (631) 265-7671 | Smithtown Primary Medical Care, P.c. 100 Maple Ave Smithtown NY 11787-3502 Ph: (631) 265-7671 |
NPI Number | 1326243536 |
---|---|
Provider Enumeration Date | 06/18/2007 |
Last Update Date | 09/29/2011 |
Medicare PECOS PAC ID | 2163609579 |
---|---|
Medicare Enrollment ID | O20110613000565 |
News Archive
Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.
Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.
Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1326243536 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 120634-1 (New York) | Primary |
Provider Name | Ronald Roth |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1891870234 PECOS PAC ID: 1153519053 Enrollment ID: I20110613000398 |
News Archive
Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.
Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.
Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).
› Verified 9 days ago
Provider Name | Priscilla Lamura |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1124749130 PECOS PAC ID: 2961875455 Enrollment ID: I20230303000708 |
News Archive
Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.
Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.
Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).
› Verified 9 days ago
Provider Name | Barbara Mazzola |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1629106695 PECOS PAC ID: 4486977204 Enrollment ID: I20240219003693 |
News Archive
Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.
Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.
Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).
› Verified 9 days ago
News Archive
Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.
Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.
Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).
› Verified 9 days ago
Raul R. Trinchet, M.d., P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 285 Middle Country Road, Suite Ll-2, Smithtown, NY 11787 Phone: 631-979-4541 Fax: 631-979-4546 | |
Pilip Medical Treatments P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 732 Smithtown Byp Ste 305, Smithtown, NY 11787 Phone: 631-656-9040 Fax: 631-648-9661 | |
Omni Medical 360 Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 Maple Ave, Smithtown, NY 11787 Phone: 631-813-7788 | |
Optimum Care Family Medicine, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 321 E Main St Ste 1, Smithtown, NY 11787 Phone: 631-265-4606 Fax: 631-265-4675 | |
Long Island Gastroenterology And Liver Disease P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 48 Route 25a Ste 307, Smithtown, NY 11787 Phone: 631-265-0062 Fax: 631-265-0590 | |
Infectious Disease Medical Practice Of Ny Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 48 Route 25a, Suite 308, Smithtown, NY 11787 Phone: 631-864-6111 Fax: 631-864-5004 | |
Vp Medical, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 20 Gilbert Ave, Smithtown, NY 11787 Phone: 347-987-1168 |